Cargando…
The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation
PURPOSE: To investigate the role of intensity-modulated proton therapy (IMPT) for hepatocellular carcinoma (HCC) patients to be treated with stereotactic body radiation therapy (SBRT) in a risk-adapted dose prescription regimen. METHODS: A cohort of 30 patients was retrospectively selected as “at-ri...
Autores principales: | Cozzi, Luca, Comito, Tiziana, Loi, Mauro, Fogliata, Antonella, Franzese, Ciro, Franceschini, Davide, Clerici, Elena, Reggiori, Giacomo, Tomatis, Stefano, Scorsetti, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727039/ https://www.ncbi.nlm.nih.gov/pubmed/33287650 http://dx.doi.org/10.1177/1533033820980412 |
Ejemplares similares
-
Dosimetric impact of volumetric modulated arc therapy for nasopharyngeal cancer treatment
por: Franzese, Ciro, et al.
Publicado: (2021) -
Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma
por: Cozzi, Luca, et al.
Publicado: (2018) -
Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients
por: Franceschini, Davide, et al.
Publicado: (2022) -
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
por: Scorsetti, Marta, et al.
Publicado: (2018) -
Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung Cancer
por: Loi, Mauro, et al.
Publicado: (2020)